NCT04098718: Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)
- State
- State not given
- Phase
- Phase 2
- People
- 158 planned
- Started
- 29 Mar 2021
- Primary completion
- 19 Feb 2024
- Arms
- Benralizumab SC + PO placebo, Benralizumab SC + PO prednisolone
- Results
- None posted
- 23 Sep 2019: Trial registered
- 29 Mar 2021: Trial started